Market News / Story
OncoZenge AB (publ) (ONCOZ) Raises SEK 3.3M in Directed Share Issue at SEK 3.00
·
OncoZenge resolved a directed issue of 1,100,000 shares at SEK 3.00, raising SEK 3.3M before costs, a ~9.5% discount to the 7 Oct close. Dilution is ~4.0%. Proceeds fund the BEAM-Pain Phase III trial and MAA preparations. Material Details #DetailAI Analyst View1SEK 3.3M raised via directed issueAdds near-term liquidity for trial and MAA prep; modest size limits runway impact.2Price SEK 3.00, ~9.5% discountDiscount benchmarks likely near-term pricing pressure for the…